Diarrhea News and Research

Latest Diarrhea News and Research

Energy drinks can have adverse health effects on youth, study reveals

Over half of Canadian youth and young adults who have consumed energy drinks have experienced negative health effects as a result, according to a study from the University of Waterloo.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

SHEA releases new guidance on contact precautions for drug-resistant infections

New expert guidance released today by the Society for Healthcare Epidemiology of America advises hospitals on determining when they can safely discontinue contact precautions for patients with multi-drug resistant bacteria.

11 Jan 2018

Warning on the “raw water” drinking trend

For a few years now several companies have been marketing “raw water” that has been bottled directly from natural sources such as springs and small water bodies without filtration and treatment.

11 Jan 2018

Malnutrition remains underdiagnosed, undertreated for decades among hospitalized patients

Malnutrition among hospitalized patients remains a serious issue that has been underdiagnosed and undertreated for decades.

9 Jan 2018

Study finds link between dietary sugar and increasing bacterial epidemics

The rising frequency and severity of Clostridium difficile infections may be caused by the commonly used food additive, trehalose, according to Nature.

5 Jan 2018

Mobidiag introduces new fully automated diagnostic solution for infectious diseases

Mobidiag, a Finnish molecular diagnostics company, launches Novodiag, a fully automated solution for syndromic and targeted testing of infectious diseases, supporting limitation of antibiotic use.

4 Jan 2018

Dietary sugar may contribute to increasing frequency, severity of bacterial epidemics

The increasing frequency and severity of healthcare-associated outbreaks caused by bacterium Clostridium difficile have been linked to the widely used food additive trehalose.

3 Jan 2018

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.

26 Dec 2017

Survey shows prevalence of diarrhea in people living with HIV

Napo Pharmaceuticals, Inc., a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc., today released the results of a survey of 350 people living with HIV and AIDS on "Talking to Your Doctor About Symptoms".

13 Dec 2017

Single-dose oral vaccine could be effective tool in controlling cholera outbreaks

Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard.

12 Dec 2017

Opioids after surgery left her addicted. Is that a medical error?

In April this year, Katie Herzog checked into a Boston teaching hospital for what turned out to be a nine-hour-long back surgery.

11 Dec 2017

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite

A research team at the University of Kent has established the first long-term cultivation system at a laboratory scale for the parasite Cryptosporidium, one of the world's worst and most common causes of diarrhea and death from diarrhea.

4 Dec 2017

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Capsule research could transform treatment for C. difficile infections

An Alberta-led clinical trial has shown Fecal Microbiota Transplant (FMT) is as effective in treating clostridium difficile (C. difficile) infections whether delivered by colonoscopy or by swallowing capsules.

28 Nov 2017

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a study published online in Blood Advances, a Journal of the American Society of Hematology.

22 Nov 2017

Researchers reduce over-prescription of antibiotics by using computer alerts to inform doctors

Physicians at Kaiser Permanente in Southern California reduced the odds of prescribing an antibiotic for sinusitis by 22 percent using computer alerts to inform doctors when antibiotics may not be the best course of treatment. The research was published today in the American Journal of Managed Care.

21 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

New health analysis in India finds increase in non-communicable diseases

A new state-by-state health analysis in India finds that over two decades heart- and lung-related conditions, as well as other non-communicable diseases (NCDs), have surpassed infectious diseases, such as diarrhea and tuberculosis, as the nation's leading killers.

14 Nov 2017

Diarrhea News and Research

Latest Diarrhea News and Research

Energy drinks can have adverse health effects on youth, study reveals

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

SHEA releases new guidance on contact precautions for drug-resistant infections

Warning on the “raw water” drinking trend

Malnutrition remains underdiagnosed, undertreated for decades among hospitalized patients

Study finds link between dietary sugar and increasing bacterial epidemics

Mobidiag introduces new fully automated diagnostic solution for infectious diseases

Dietary sugar may contribute to increasing frequency, severity of bacterial epidemics

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Survey shows prevalence of diarrhea in people living with HIV

Single-dose oral vaccine could be effective tool in controlling cholera outbreaks

Opioids after surgery left her addicted. Is that a medical error?

Kent researchers establish first long-term cultivation system for diarrhea-causing parasite

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Capsule research could transform treatment for C. difficile infections

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Researchers reduce over-prescription of antibiotics by using computer alerts to inform doctors

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

New health analysis in India finds increase in non-communicable diseases

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in